Last Update 22 Mar 26

Fair value Decreased 3.46%

DOX: Reset Guidance And Capital Returns Will Support Multiple Rerating

Analysts have trimmed their Amdocs fair value estimate by about $3.25 to $90.57, citing slightly softer revenue growth and profit margin assumptions, partly offset by a higher forward P/E multiple.

Analyst Commentary

Bullish Takeaways

Bullish analysts point to the maintained use of a higher forward P/E multiple in fair value work, which suggests ongoing confidence in Amdocs' earnings quality and pricing power, even with more conservative revenue and margin inputs.
Some see the revised fair value of about $90.57 as still supportive of a constructive view on the company, indicating that recent adjustments are more about fine tuning assumptions than a fundamental shift in the story.
The partial offset from the higher multiple is viewed as a sign that Amdocs' business model and execution track record continue to warrant a valuation premium relative to more uncertain peers.
Bullish analysts also highlight that the recalibration of expectations can lower the hurdle for future execution, which may reduce downside risk if Amdocs simply delivers in line with the updated assumptions.

Bearish Takeaways

Bearish analysts focus on the trimmed fair value estimate and reduced price targets, seeing the lower numbers as a signal that prior expectations for revenue expansion and margin resilience may have been too optimistic.
The reference to slightly softer revenue growth and profit margin assumptions reflects concern that Amdocs could face pressure on both top line and profitability, which would weigh on earnings power if it materializes.
Some are cautious that the reliance on a higher forward P/E multiple to support the updated valuation could leave the stock vulnerable if sentiment toward the sector, or valuation multiples generally, weakens.
There is also a view that, with targets being reset, the risk reward profile is more balanced, as downside from any execution hiccups or contract timing issues could have a faster impact on the valuation than upside from incremental wins.

What's in the News

Amdocs revised its fiscal 2026 earnings outlook, with revenue growth now expected in a 1.5% to 5.5% range and GAAP diluted EPS growth guidance at 10.0% to 17%, compared with prior guidance of 1.7% to 5.7% revenue growth and 13.5% to 20.5% GAAP diluted EPS growth (Corporate Guidance - Lowered).
The company issued guidance for the second quarter of fiscal 2026, targeting revenue between US$1.150b and US$1.190b and GAAP diluted EPS of US$1.22 to US$1.30 (Corporate Guidance - New/Confirmed).
Between October 1, 2025 and December 31, 2025, Amdocs repurchased 1,815,796 shares for US$146m, completing a total of 1,978,628 shares repurchased for US$159.6m under the buyback announced on May 8, 2025 (Buyback Tranche Update).
On February 3, 2026, the board approved the next quarterly cash dividend at a new rate of US$0.569 per share, with a record date of March 31, 2026 and payment scheduled for April 24, 2026 (Dividend Increases).

Valuation Changes

Fair Value: reduced slightly from $93.82 to $90.57, reflecting modestly more conservative modeling inputs.
Discount Rate: eased slightly from 9.50% to about 9.45%, indicating a marginal adjustment to the assumed risk profile.
Revenue Growth: trimmed slightly from about 4.10% to about 4.04% in the long term assumptions.
Net Profit Margin: lowered more meaningfully from about 17.64% to about 15.65%, pointing to a softer earnings power assumption.
Future P/E: raised from about 13.11x to about 14.28x, indicating a somewhat higher valuation multiple applied to projected earnings.

8 views

Key Takeaways

Strong adoption of cloud, AI, and next-generation telecom solutions is expanding Amdocs' growth opportunities and strengthening revenue stability through recurring high-visibility contracts.
Amdocs' leadership in SaaS, automation, and integrated BSS/OSS offerings is driving margin improvement and a robust pipeline for future growth.
Heavy dependence on a few key telecom clients and slow growth in cloud, SaaS, and GenAI services could restrain revenue stability and future earnings.

Catalysts

About Amdocs

Through its subsidiaries, provides software and services to communications, entertainment, and media service providers worldwide.What are the underlying business or industry changes driving this perspective?

The accelerating adoption of cloud, automation, and AI/ML across telecom and media sectors is driving a multi-year wave of IT stack modernization, with Amdocs winning new large-scale modernization and migration deals in cloud, generative AI, and data services-this is expanding its total addressable market and supporting sustained topline revenue growth.
The rapid shift to 5G and next-generation wireless is prompting significant investment from telecom providers in digital transformation and core systems upgrades, which Amdocs is capturing through high-visibility managed service contracts (with notable wins and extensions in Europe, North America, and Asia), thereby boosting recurring revenue and earnings stability.
Customer conversions from generative AI proof-of-concepts (POCs) to production rollouts are increasing, creating a growing pipeline of incremental revenue and potential for future net margin expansion as Amdocs leads in deploying AI-powered platforms for automation and customer experience.
Expansion of SaaS-based and cloud-native product lines, including ConnectX and eSIM platforms, is delivering double-digit growth and higher gross margins, improving both earnings visibility and operating margins as recurring revenue scales.
Increased demand for complex BSS/OSS solutions due to convergence of mobile, broadband, fiber and new digital brands is emerging as telcos seek to streamline operations and support new business models, favoring Amdocs' integrated offerings and driving backlog and forward-looking revenue higher.

Amdocs Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Amdocs's revenue will grow by 4.0% annually over the next 3 years.
Analysts assume that profit margins will increase from 12.5% today to 15.6% in 3 years time.
Analysts expect earnings to reach $806.7 million (and earnings per share of $7.46) by about March 2029, up from $571.1 million today.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 14.3x on those 2029 earnings, up from 12.2x today. This future PE is lower than the current PE for the US IT industry at 19.4x.
Analysts expect the number of shares outstanding to decline by 3.28% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 9.45%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

Persistent macroeconomic and geopolitical uncertainty is impacting customer spending behavior, with no signs of improvement in telco and media capital expenditures; this could constrain Amdocs' forward revenue growth and create earnings pressure if clients delay or reduce digital transformation budgets.
Client concentration risk remains elevated, as major wins and growth opportunities are tied to a handful of large telecom operators; customer attrition, contract renegotiations, or consolidation among these key clients could destabilize long-term revenue and diminish backlog visibility.
The shift to SaaS and cloud-native offerings, while showing traction, is not yet generating "hundreds of millions" in annual revenue and remains a relatively small portion of overall sales; slower than expected scaling of cloud revenues or failure to keep pace with nimbler, cloud-first competitors could compress both revenue and net margins.
Ongoing reliance on large, complex, multi-year transformation projects creates cyclical volatility and earnings risk-delays, project overruns, or customer-side migration challenges (as evidenced by long cloud migration timelines) could negatively impact revenue recognition and margin stability.
Expansion into GenAI and data services is in the early stages, with current contributions only "small increments" and customers still in exploratory phases; if GenAI deployment cycles remain protracted or prove less disruptive than expected, Amdocs may face slower growth in new business lines, limiting future revenue acceleration and hampering earnings expansion.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of $90.57 for Amdocs based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $105.0, and the most bearish reporting a price target of just $70.84.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $5.2 billion, earnings will come to $806.7 million, and it would be trading on a PE ratio of 14.3x, assuming you use a discount rate of 9.4%.
Given the current share price of $64.83, the analyst price target of $90.57 is 28.4% higher.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Amdocs?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Cloud, AI And 5G Adoption Will Modernize Telecom And Media